PF-Atlas › Clinical Trials › NCT01983774
Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
Esomeprazole · Phase 2
Registry ID
NCT01983774
Phase
Phase 2
Status
Completed
Drug / intervention
Esomeprazole
Sponsor
Columbia University
Start
2008-02
About this trial
Esomeprazole is evaluated in NCT01983774, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Columbia University. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01983774 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.